French HealthTech Innovator Lifeaz Secures €13M for Defibrillator Democratization
February 17, 2026, 9:39 am
Location: France, Brittany, Saint-Jacques-de-la-Lande
Employees: 11-50
Founded date: 2003
Lifeaz, a French HealthTech firm, raised €13 million. The funding aims to democratize defibrillator access. It targets both homes and businesses. The company plans to save 1,000 lives in five years. European expansion is a key objective. Lifeaz offers user-friendly, connected AEDs. Comprehensive training empowers citizens to act. This investment accelerates growth. It enhances critical public health infrastructure. The mission focuses on widespread device availability and preparedness.
A Paris-based startup just secured €13 million in new funding. Lifeaz focuses on widespread defibrillator access. This capital infusion accelerates its growth plans. It prepares for a significant European rollout. The company aims to save 1,000 lives within five years. This marks a pivotal moment for public health initiatives.
Sudden cardiac arrest remains a leading cause of death. Survival hinges on immediate action. A defibrillator applied within minutes drastically increases chances. Yet, these critical devices are often inaccessible. Many people lack the confidence to intervene. Lifeaz directly addresses these urgent challenges.
Founded in 2015, Lifeaz developed innovative solutions. It created the first defibrillator designed for home use. A version for businesses soon followed. Its device, Clark, is engineered for simplicity. It provides clear visual and audio guidance. Even untrained individuals can operate it effectively. This ease of use shatters a major barrier to intervention.
Connectivity powers Lifeaz's approach. Each device features remote monitoring. Daily technical self-tests ensure readiness. This connected technology guarantees operational status. Maintenance needs are tracked automatically. Consumables are replaced proactively. Such features remove crucial worries for users.
Training is another core pillar. Lifeaz offers diverse educational programs. An intuitive app guides users. Video sessions provide visual learning. In-person training workshops build confidence. These resources empower citizens. They learn vital life-saving actions. Preparedness boosts the willingness to act in emergencies.
Lifeaz employs a practical business model. It offers a turnkey rental solution. This package combines the defibrillator itself. It includes connected maintenance services. Consumables replacement is part of the deal. Comprehensive training completes the offering. This model makes advanced medical technology accessible. It removes financial and logistical hurdles for organizations.
This fresh capital fuels ambitious goals. Lifeaz has already saved over 100 lives. Its new target is 1,000 lives within half a decade. The company plans significant customer expansion. It projects growth from 25,000 to over 100,000 customers. This massive scale-up demands new talent. Around 20 new hires are expected in 2026.
Investor confidence propelled this round. Existing investor Mutuelles Impact reaffirmed its support. This fund is initiated by La Mutualité Française. XAnge manages it in partnership with Impactivist. New leading investors joined the effort. BNP Paribas contributed substantial capital. GO CAPITAL and Mirova, an affiliate of Natixis, also invested. This broad support underscores Lifeaz's potential impact.
The broader HealthTech landscape shows strong activity. Cardiovascular innovation attracts significant investment. Other companies also advance cardiac care technology. Bordeaux and Tours-based FineHeart recently closed a €35 million Series C round. This clinical-stage firm develops advanced cardiovascular devices. Oxford-based Ultromics secured €48 million in its Series C. Ultromics specializes in AI-driven cardiology diagnostics. Bordeaux-based DESKi raised €5.2 million in a Seed round. Its FDA-approved cardiac imaging software, HeartFocus, is launching globally. Helsinki-based AIATELLA raised €2 million. It aims to prevent 100 million strokes with AI-powered imaging. This vibrant ecosystem highlights a shared commitment to heart health.
Lifeaz positions itself firmly within this innovative sector. Its focus on accessibility differentiates it. Many HealthTech advancements target clinical settings. Lifeaz brings critical technology directly to communities. It places life-saving tools in homes and workplaces. This strategy aims for a truly democratized impact.
European expansion represents a major strategic move. The initial focus is within France. Broader rollout across the continent follows. This geographical growth multiplies potential impact. It addresses varying regulatory environments. It tackles diverse public health needs. A unified approach to AED availability could transform outcomes across Europe.
The company's vision is expansive. It imagines a world where a defibrillator is always nearby. It envisions confident individuals ready to act. Whether at home, work, or in public spaces. This vision transforms emergency response. It shifts from specialized medical personnel to everyday citizens. Lifeaz makes everyone a potential life-saver.
Lifeaz embodies crucial innovation. It simplifies complex medical devices. It integrates maintenance and training. It prioritizes user empowerment. The company's commitment extends beyond product sales. It fosters a culture of preparedness. This comprehensive approach maximizes life-saving potential. It sets a new standard for public access defibrillation.
This funding marks a powerful validation. It confirms the urgent need for Lifeaz's solutions. It enables a dramatic scale-up of its mission. Widespread defibrillator access is no longer a distant dream. Lifeaz is making it a reality. More lives will be saved. Communities will become safer. This HealthTech venture truly impacts global well-being.
A Paris-based startup just secured €13 million in new funding. Lifeaz focuses on widespread defibrillator access. This capital infusion accelerates its growth plans. It prepares for a significant European rollout. The company aims to save 1,000 lives within five years. This marks a pivotal moment for public health initiatives.
Sudden cardiac arrest remains a leading cause of death. Survival hinges on immediate action. A defibrillator applied within minutes drastically increases chances. Yet, these critical devices are often inaccessible. Many people lack the confidence to intervene. Lifeaz directly addresses these urgent challenges.
Founded in 2015, Lifeaz developed innovative solutions. It created the first defibrillator designed for home use. A version for businesses soon followed. Its device, Clark, is engineered for simplicity. It provides clear visual and audio guidance. Even untrained individuals can operate it effectively. This ease of use shatters a major barrier to intervention.
Connectivity powers Lifeaz's approach. Each device features remote monitoring. Daily technical self-tests ensure readiness. This connected technology guarantees operational status. Maintenance needs are tracked automatically. Consumables are replaced proactively. Such features remove crucial worries for users.
Training is another core pillar. Lifeaz offers diverse educational programs. An intuitive app guides users. Video sessions provide visual learning. In-person training workshops build confidence. These resources empower citizens. They learn vital life-saving actions. Preparedness boosts the willingness to act in emergencies.
Lifeaz employs a practical business model. It offers a turnkey rental solution. This package combines the defibrillator itself. It includes connected maintenance services. Consumables replacement is part of the deal. Comprehensive training completes the offering. This model makes advanced medical technology accessible. It removes financial and logistical hurdles for organizations.
This fresh capital fuels ambitious goals. Lifeaz has already saved over 100 lives. Its new target is 1,000 lives within half a decade. The company plans significant customer expansion. It projects growth from 25,000 to over 100,000 customers. This massive scale-up demands new talent. Around 20 new hires are expected in 2026.
Investor confidence propelled this round. Existing investor Mutuelles Impact reaffirmed its support. This fund is initiated by La Mutualité Française. XAnge manages it in partnership with Impactivist. New leading investors joined the effort. BNP Paribas contributed substantial capital. GO CAPITAL and Mirova, an affiliate of Natixis, also invested. This broad support underscores Lifeaz's potential impact.
The broader HealthTech landscape shows strong activity. Cardiovascular innovation attracts significant investment. Other companies also advance cardiac care technology. Bordeaux and Tours-based FineHeart recently closed a €35 million Series C round. This clinical-stage firm develops advanced cardiovascular devices. Oxford-based Ultromics secured €48 million in its Series C. Ultromics specializes in AI-driven cardiology diagnostics. Bordeaux-based DESKi raised €5.2 million in a Seed round. Its FDA-approved cardiac imaging software, HeartFocus, is launching globally. Helsinki-based AIATELLA raised €2 million. It aims to prevent 100 million strokes with AI-powered imaging. This vibrant ecosystem highlights a shared commitment to heart health.
Lifeaz positions itself firmly within this innovative sector. Its focus on accessibility differentiates it. Many HealthTech advancements target clinical settings. Lifeaz brings critical technology directly to communities. It places life-saving tools in homes and workplaces. This strategy aims for a truly democratized impact.
European expansion represents a major strategic move. The initial focus is within France. Broader rollout across the continent follows. This geographical growth multiplies potential impact. It addresses varying regulatory environments. It tackles diverse public health needs. A unified approach to AED availability could transform outcomes across Europe.
The company's vision is expansive. It imagines a world where a defibrillator is always nearby. It envisions confident individuals ready to act. Whether at home, work, or in public spaces. This vision transforms emergency response. It shifts from specialized medical personnel to everyday citizens. Lifeaz makes everyone a potential life-saver.
Lifeaz embodies crucial innovation. It simplifies complex medical devices. It integrates maintenance and training. It prioritizes user empowerment. The company's commitment extends beyond product sales. It fosters a culture of preparedness. This comprehensive approach maximizes life-saving potential. It sets a new standard for public access defibrillation.
This funding marks a powerful validation. It confirms the urgent need for Lifeaz's solutions. It enables a dramatic scale-up of its mission. Widespread defibrillator access is no longer a distant dream. Lifeaz is making it a reality. More lives will be saved. Communities will become safer. This HealthTech venture truly impacts global well-being.